Annual Report and Accounts and Notice of Annual General Meeting
Kin Group PLC (AIM:KIN) Bidstack Limited – Transaction update – RTO
Kin Group Plc (“Kin” or “the Company”) Bidstack Limited (“Bidstack”) – Transaction update The Directors of Kin are pleased to provide an update, further to the announcement on 5
Abzena PLC (AIM:ABZA) Recommended Cash Offer for Abzena plc
Astro Bidco Limited, a company wholly-owned by WCAS XII-Astro, L.P.
Feedback plc (AIM:FDBK) First GE Healthcare order for TexRAD® medical imaging software
Feedback plc (AIM: FDBK, “Feedback” or the “Company”), the specialist medical imaging technology company, announces that its operating company Feedback Medical Ltd has received its first order via GE
SalvaRx Group plc (AIM:SALV) Proposed disposal of interest in SalvaRx Limited
SalvaRx Group plc (AIM: SALV), a biotechnology company focused on discovering and developing immunotherapies for cancer, announces that it has entered into a conditional sale agreement (the “Sale Agreement”)
Faron Pharmaceuticals Ltd (LON: FARN) Notice of Interim Results
TURKU – FINLAND, 8 August 2018 – Faron Pharmaceuticals Ltd (“Faron”) (AIM: FARN), the clinical stage biopharmaceutical company, will be announcing its interim results for the six months ended 30
Ovoca Gold PLC (LON:OVG) Readmission to trading on AIM and ESM
Further to the announcement by the Company on 27 July regarding the approval of the Resolutions relating to the Transaction, Ovoca is pleased to announce the admission of its
Avacta Group PLC (LON:AVCT) Major Therapeutics Co-development Partnership
Collaboration Based on Ground-breaking Co-Invention with Tufts University School of Medicine Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has
David Budd, CEO, Genedrive PLC (LON:GDR) Interview
Share Talk caught up with Manchester based company Genedrive PLC and spoke with David Budd, CEO about the company progress and what he has planned for the future.
NHS: The National Death Service – A British Dignitas
There would appear to be such an aggressive approach to end of life “care” from the NHS one could say that rather than flying all the way from to
Totally PLC (LON:TLY) Results for the 15-month period ended 31 March 2018
Pre-tax profit for the 15 months through March was £2.1m, comparing to a loss of £1.5m for the 12 months through December.
Ananda Developments plc (TIDM: ANA) Admission to trading on the NEX Exchange
Ananda Developments plc (TIDM: ANA) is pleased to announce that trading in the 329,166,666 ordinary shares of 0.2 pence each in the Company (“Ordinary Shares”) shall commence at 8.00am,
